SAN DIEGO and PENNINGTON, N.J., March 9, 2020 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec"), a company developing late-stage intratumoral cancer immunotherapies, today announced that the class action and related books and records litigation brought by Alpha Holdings, Inc. ("Alpha")  in

LAS VEGAS, March 8, 2020 /PRNewswire/ -- Keep Memory Alive's 24th annual

BRIDGEWATER, N.J., March 9, 2020 /PRNewswire/ -- Menlo Therapeutics Inc. (Nasdaq: MNLO) ("Menlo" or the "Company") announced today the completion of its merger with Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) ("Foamix") following the satisfaction of all closing conditions required by the merger agreement. Upon completion of the merger, pursuant to the terms of

HOUSTON, March 9, 2020 /PRNewswire/ -- CarePay™ a Houston-based healthcare IT company, has announced a re-branding to SOAFEE™.  The SOAFEE™ platform focuses on consumers, employers, and providers.  Consumers are forced to pay out-of-pocket for their healthcare - if

NEW YORK, March 9, 2020 /PRNewswire/ -- Lighthouse Guild, the leading not-for-profit vision and healthcare organization, today announced that Gerrit Melles, MD, PhD from The Netherlands has been awarded the 2020 Bressler Prize for his outstanding advances in vision science, particularly in the field of

SAN DIEGO, March 9, 2020 /PRNewswire/ -- Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable infor

HOUSTON, March 9, 2020 /PRNewswire/ -- ZT Corporate, a private equity firm that specializes in healthcare and automotive companies, and

OAKLAND, Calif. and SAN DIEGO, March 9, 2020 /PRNewswire/ -- Blue Shield of California has become the first health plan in the United States to cover rapid and ultra-rapid Whole Genome Sequencing to help critically ill babies and children in intensive care with un

MARLBOROUGH, Mass., March 9, 2020 /PRNewswire/ -- BTL, the manufacturer behind the revolutionary EMSCULPT technology, is continuing to set-the-pace in aesthetics and non-invasive body shaping and contouring. Today, the brand announced the launch of the new EMSELLA applicator with up to 2.5 Tesla (T) to treat all forms of male and female urinary incontinen

MORRISTOWN, N.J., March 9, 2020 /PRNewswire/ -- In a recent study conducted by KMK Consulting, Inc., covering Innovation & Customer Value in the Breast Cancer market, Genentech (a member of the Roche Group) was ranked as the top company delivering superior customer value and sales force engagement, as well as delivering therapeutic innovation in this space.